TY - JOUR
AU - Lees, Charlie W.
AU - Irving, Peter M.
AU - Beaugerie, Laurent
PY - 2020
DA - November
TI - COVID-19 and IBD drugs: should we change anything at the moment?
JO - Gut
EP - 634
VL - 70
IS - 4
DO - https://doi.org/10.1136/gutjnl-2020-323247
AB - The COVID-19 pandemic has raised questions about the management of people with inflammatory bowel disease (IBD).To date, there have been over 43 million confirmed cases of COVID-19 globally, including over 1.1 million deaths (https://COVID-19.who.int). What have we learnt about the risks of SARS-CoV-2 infection in patients with IBD and is there any evidence to support a change in IBD management?
PB - BMJ Publishing Group
UR - https://www.research.ed.ac.uk/portal/en/publications/covid19-and-ibd-drugs(0dc04993-b048-4392-98f2-aecc6dfc534b).html
KW - Coronavirus (COVID-19)
ER